Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934. (Q45915490)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934. |
scientific article published in October 2009 |
Statements
1 reference
Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934. (English)
1 reference
Nicolas A Margot
1 reference
Jeff Enejosa
1 reference
Andrew K Cheng
1 reference
Michael D Miller
1 reference
Damian J McColl
1 reference
Study 934 Team
1 reference
1 October 2009
1 reference
52
1 reference
2
1 reference
209-221
1 reference